SCHEMBL1522498

SCHEMBL1522498

Cc1ccc(Br)c(S(N)(=O)=O)c1NC(=O)c1c(O)c2cccnc2n(Cc2ccccc2)c1=O

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 6/20 0.53
CNR1 P21554 2/20 0.53
KDM4E B2RXH2 5/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 2/20 0.47
POLB P06746 1/20 0.47
HIF1A Q16665 1/20 0.45
USP2 O75604 2/20 0.45
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1522964 0.91 CNR2 (0.53) CNR2CNR1KDM4ESMN1; SMN2MAPT
SCHEMBL1522754 0.90 CNR2 (0.51) CNR2CNR1KDM4ESMN1; SMN2MAPT
SCHEMBL1522518 0.87 CNR2 (0.55) CNR2CNR1KDM4ESMN1; SMN2MAPT
SCHEMBL1522556 0.84 CNR2 (0.56) CNR2CNR1KDM4ESMN1; SMN2HIF1A
SCHEMBL1522261 0.82 CNR2 (0.55) CNR2CNR1KDM4ESMN1; SMN2MAPT
SCHEMBL1523115 0.81 CNR2 (0.60) CNR2CNR1KDM4ESMN1; SMN2MAPT
SCHEMBL1522667 0.80 CNR2 (0.53) CNR2CNR1KDM4ESMN1; SMN2MAPT
SCHEMBL1522333 0.80 CNR2 (0.53) CNR2CNR1KDM4ESMN1; SMN2MAPT
SCHEMBL1522633 0.79 CNR2 (0.54) CNR2CNR1KDM4ESMN1; SMN2HIF1A
SCHEMBL1522406 0.79 KDM4E (0.56) CNR2CNR1KDM4ESMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902203-B2 Anti-infective agents ABBOTT LABORATORIES, INC. (US) 2011-03-08 US disclosed
EP-1560827-B1 ANTI-INFECTIVE AGENTS ABBOTT LAB (US) 2010-12-29 EP disclosed
EP-1560827-A1 ANTI-INFECTIVE AGENTS Abbott Laboratories (US) 2005-08-10 EP disclosed
US-20050075331-A1 Anti-infective agents ABBOTT LABORATORIES 2005-04-07 US disclosed
US-20040167123-A1 Anti-infective agents ABBVIE INC. 2004-08-26 US disclosed
US-20040162285-A1 Anti-infective agents ABBOTT LABORATORIES 2004-08-19 US disclosed
WO-2004041818-A1 ANTI-INFECTIVE AGENTS ABBOTT LABORATORIES (US) 2004-05-21 WO disclosed
US-20040097492-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-20 US disclosed
US-20040087577-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097492-A1 Anti-infective agents POLR1C, RPL5, POLB CNR2 4494/4885CNR1 3398/4885KDM4E 4352/4885
US-20040162285-A1 Anti-infective agents POLR1C, RPL5, POLB CNR2 4494/4885CNR1 3398/4885KDM4E 4352/4885
US-20040167123-A1 Anti-infective agents SERPINB1, CYP51A1, ZC3HAV1 CNR2 4140/4885CNR1 2252/4885KDM4E 4075/4885
US-20050075331-A1 Anti-infective agents RPL35, POLI, POLRMT CNR2 4150/4885CNR1 3251/4885KDM4E 3897/4885
US-20040087577-A1 Anti-infective agents POLR1C, RPL5, POLB CNR2 4494/4885CNR1 3398/4885KDM4E 4352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.